EP2292636
Aðferð til þéttingar á mótefnum og meðferðarafurðum þar af
Status:
EP Einkaleyfi útrunniðEP appl. date:
8.9.2005EP published:
18.10.2023EP application number:
10009914.2
EP translation filed:
10.1.2024Grant published:
15.2.2024EPO information:
European Patent Register
Max expiry date:
7.9.2025Expiry date:
7.9.2025
Title in English:
Process for concentration of antibodies and therapeutic products thereofLanguage of the patent:
English
Timeline
Today
8.9.2005EP application
18.10.2023EP Publication
10.1.2024Translation submitted
15.2.2024Registration published
7.9.2025Expires
Owner
Name:
Genentech, Inc.Address:
1 DNA Way, South San Francisco, CA 94080-4990, US
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
Winter, Charles MatthewAddress:
Belmont, CA 94002, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
609092 PDate:
9.9.2004Country:
US
Number:
220362Date:
6.9.2005Country:
US
Classification
Categories:
C07K 1/34
Annual fees
Number
Paid
Expires
Payer
Number: 20
Paid: 22.8.2024
Expires: 7.9.2025
Payer: Árnason Faktor ehf.